Age-related macular degeneration: genetic and environmental factors of disease
about
Update on Clinical Trials in Dry Age-related Macular DegenerationGenetics of immunological and inflammatory components in age-related macular degenerationSerological association of Chlamydia pneumoniae infection with age-related macular degeneration: a systematic review and meta-analysisNLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen componentsNovel common variants and susceptible haplotype for exfoliation glaucoma specific to Asian population.Biological effects of cigarette smoke in cultured human retinal pigment epithelial cells.JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration.Aryl hydrocarbon receptor knock-out exacerbates choroidal neovascularization via multiple pathogenic pathways.The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study.Metabolome-wide association study of neovascular age-related macular degenerationVariability of the transferrin receptor 2 gene in AMD.Modeling human disease in humans: the ciliopathies.An association between polymorphism of the heme oxygenase-1 and -2 genes and age-related macular degeneration.Management of retinal vascular diseases: a patient-centric approach.An association between environmental factors and the IVS4+44C>A polymorphism of the DMT1 gene in age-related macular degenerationGenetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics.P16INK4a Upregulation Mediated by SIX6 Defines Retinal Ganglion Cell Pathogenesis in GlaucomaProtective effect of autophagy on human retinal pigment epithelial cells against lipofuscin fluorophore A2E: implications for age-related macular degenerationTargeting inflammation in emerging therapies for genetic retinal diseaseNo association of age-related maculopathy susceptibility protein 2/HtrA serine peptidase 1 or complement factor H polymorphisms with early age-related maculopathy in a Chinese cohort.Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD).Carboxyethylpyrrole plasma biomarkers in age-related macular degeneration.Increase in peripheral blood mononuclear cell Toll-like receptor 2/3 expression and reactivity to their ligands in a cohort of patients with wet age-related macular degeneration.Common variant in VEGFA and response to anti-VEGF therapy for neovascular age-related macular degeneration.Aging is not a disease: distinguishing age-related macular degeneration from aging.Evaluating Potential Therapies in a Mouse Model of Focal Retinal Degeneration with Age-related Macular Degeneration (AMD)-Like Lesions.Genetic variants in microRNAs and their binding sites within gene 3'UTRs associate with susceptibility to age-related macular degeneration.TRPV4 channels mediate the infrared laser-evoked response in sensory neurons.Toll-like receptor 3 (TLR3) protects retinal pigmented epithelium (RPE) cells from oxidative stress through a STAT3-dependent mechanism.CFH polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.Factors affecting the use of antioxidant supplements in patients with late AMD.Whole-exome sequencing implicates UBE3D in age-related macular degeneration in East Asian populations.Vitamin D and Age-Related Macular Degeneration.Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.Automated visual choice discrimination learning in zebrafish (Danio rerio).Metallothionein polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.MicroRNA-processing Enzymes Are Essential for Survival and Function of Mature Retinal Pigmented Epithelial Cells in Mice.Toll-Like Receptors 2 and 4 Polymorphisms in Age-Related Macular Degeneration.Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: significant association of twelve variants.Lutein supplementation leads to decreased soluble complement membrane attack complex sC5b-9 plasma levels
P2860
Q26767098-7C942E8C-B7E2-4336-A303-A2F12E0D6F39Q26849231-2D38790A-03C7-4F3E-91E0-6B378FB06794Q27006867-AB7F91D4-B607-44E8-B1F5-2CF769C2E576Q30576000-D8DFF001-9435-4C92-A3E3-EA7B2EA216B8Q33771017-D33C2065-B9E0-4F4A-9794-3F3D52969AEDQ34479008-49FA27B6-B832-481A-8E47-AF2D679F7AD3Q34557890-05DD99BC-9A70-42EB-8AA3-66317245238BQ34778661-A47FCE85-627E-43B5-8D90-430BA225DA67Q34907493-B7099A28-9FDC-49E2-AC23-05AC9B29A42DQ34981613-A4021158-A571-443B-9108-3820703F0904Q35125539-BAE2576B-41FA-424C-A663-CE418AE42CABQ35453921-CD7B30E2-D896-41D1-8A6D-28E7204073C1Q35730294-D3A3DBC5-4730-4BE5-A485-B403EC827AD4Q35909406-4B3DDB4E-8C5C-4EB6-86AD-CBC43916D1BEQ36056865-A04E35DB-558A-4310-90E5-943888366977Q36084168-8C04E96D-9397-4683-AC6E-4B5A3A566192Q36289322-B35EB0B7-33B7-4550-9862-8B6898F5E53FQ36349956-8B4101FD-1BA1-4E18-AF7D-D50737EEF44AQ36676772-3128CFEF-43F8-424A-88F3-6692D3A08F57Q36846624-06FCB01D-F02E-4C26-BC26-6D219626D2ACQ36933119-7C77A0AD-AAF1-41BA-8100-CDCC4EF85D80Q36995212-A4E89ED8-1A9C-46DE-B897-5937926C5507Q37091562-4DCFB043-BBBE-4C54-A598-7A9EEDD9F664Q37246901-0D360182-A5AD-4019-B9B8-52F852B32C28Q37315838-7EB105EF-D4A8-4527-9FCB-D974D71CBE52Q37472652-171E77AA-8D7E-4668-AB9D-8C0814473356Q38843160-60AB5523-1BAB-447F-801D-6B9BDF2F7EF9Q39637320-86EC9B48-93C8-4F70-A6B0-D28393BEF258Q40252520-2E1100F7-2447-454E-B89B-6D96E65C25B4Q41604701-FBBCB86D-3A2F-4578-A4BE-51D77D9ADDE2Q41870674-B6F22C73-789C-4B71-BFB0-69596F2F1A6BQ46716950-B59D1999-6850-4FF0-A3D7-BC05CEF39BF0Q47100212-07DF5EEC-14B5-4E73-A2ED-C7DDF82E6B9CQ47253521-3F8F56D6-03CC-49C2-90C2-120981E96B14Q48457178-C7310A39-7D3D-4808-B1BB-9FB6D230AD7BQ50932453-D3FF1AC3-7F0D-454C-85F6-FBD6AE4B80DEQ51180532-C2B9ED64-7245-433A-AD43-0E9A455E2E9EQ53520625-C57D26EE-97AD-4507-9C48-311B56E95940Q54965254-5A6DFB13-877E-438C-B1FE-3A29009703DBQ57337541-1358CF2B-DAF8-4AB4-B7AF-72BA2689D7C2
P2860
Age-related macular degeneration: genetic and environmental factors of disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Age-related macular degeneration: genetic and environmental factors of disease
@ast
Age-related macular degeneration: genetic and environmental factors of disease
@en
Age-related macular degeneration: genetic and environmental factors of disease
@nl
type
label
Age-related macular degeneration: genetic and environmental factors of disease
@ast
Age-related macular degeneration: genetic and environmental factors of disease
@en
Age-related macular degeneration: genetic and environmental factors of disease
@nl
prefLabel
Age-related macular degeneration: genetic and environmental factors of disease
@ast
Age-related macular degeneration: genetic and environmental factors of disease
@en
Age-related macular degeneration: genetic and environmental factors of disease
@nl
P2093
P2860
P356
P1476
Age-related macular degeneration: genetic and environmental factors of disease
@en
P2093
Kang Zhang
Matthew Bedell
Yuhong Chen
P2860
P304
P356
10.1124/MI.10.5.4
P577
2010-10-01T00:00:00Z